Page 1599 - Small Animal Internal Medicine, 6th Edition

Index 1571

Potassium (Continued) Pregnancy (Continued) Progesterone, 942–943 Protein-losing nephropathy
description of, 66 progesterone levels necessary for, Progesterone-secreting adrenal tumors, antithrombin deficiency caused by,
893, 894f
223
diabetic ketoacidosis treated with, termination of Progestogens, 749 diagnosis of, 1249–1250
962–963
VetBooks.ir guidelines for, 917t antiestrogens for, 959 Proglycem. see Diazoxide Protein-to-creatinine ratio, 661–662
843
fluid therapy in, 434
hypernatremia treated with, 917t
antiprogestational agents for, 960
Progressive rear limb ataxia, 1146f
Potassium bromide, 1102–1103,
description of, 1142–1156
in chronic kidney disease, 681, 681b
dopaminergic compounds, 960
1185t–1186t dexamethasone for, 960 Progressive spinal cord dysfunction Proteinuria, 678, 862
Potassium chloride, 922 estrogens for, 959 diskospondylitis, 1143–1144, clinical approach to, 681b
Potassium gluconate, 934t, 1185t–1186t overview of, 959–960, 959f 1143f–1144f diagnostic tests for, 1218t–1219t
Potentiated sulfas, 1437t–1438t prostaglandins for, 960 infectious inflammatory disease, heartworm disease as cause of, 197
PR interval, 26t thrombosis in, 967, 967f 1142–1143 Proton pump inhibitors (PPIs), 439,
Pradofloxacin, 386t–388t, 1437t–1438t ultrasound diagnosis of, 950, 950f neoplasia 439t, 456
Pralidoxime chloride, 1185t–1186t vaccination during, 961 clinical features of, 1145 Protonix. see Pantoprazole
Praziquantel, 386t–388t, 444t, 515t–517t Pregnancy toxemia, 967 description of, 1145–1147, 1145f Prototheca zopfii, 484
for liver fluke infestation, 573 Prehensile disorder, 391 noninfectious inflammatory disease, Protothecosis, 484, 485f
Prazosin, 733t–734t Prekallikrein, 1387–1388, 1393 1143 Protozoal diseases, 965–966
chronic heart failure treated with, 64t, Preleukemic syndrome, 1312–1313 spinal arachnoid diverticula, systemic, 1430
71 Premature ectopic rhythm, 38–39 1147–1148 Protozoal infections
hypertension treated with, 217t Premature myometrial activity, 962 subacute, 1142–1144 American trypanosomiasis, 1525–1526
Prebiotics, 443 Premature ovarian failure, 956 type II intervertebral disk disease, babesiosis, 154, 1514–1516
Precordial impulse, 6 Premature uterine activity, 962 1148 canine toxoplasmosis, 1525
Precordial thrill, 6 Preprohormones, 13 Proliferative glomerulonephritis, 678 cytauxzoonosis, 1516–1517
Precordium, 6 Prerenal azotemia, 649, 686–687 PromAce. see Acepromazine feline toxoplasmosis, 1521–1525
Prednisolone, 515t–517t Pressure gradient estimation, 30–31 Propafenone hepatozoonosis, 1517–1518
administration of, 332 Presyncope, 1–2 description of, 93 leishmaniosis, 1518–1520
atrophic myositis treated with, 451 Presystolic gallop, 9 in dogs, 90t–91t neosporosis, 154, 1118t, 1127–1128,
eosinophilic gastritis treated with, 463 Preterm labor, 1034t–1036t dosage of, 90t–91t 1127f, 1520–1521
feline nasopharyngeal polyps treated idiopathic, 962–963, 963f–964f Propantheline bromide, 97 polysystemic, 1514–1531
with, 264 Prevacid. see Lansoprazole in dogs, 90t–91t toxoplasmosis. see Toxoplasmosis
hemolysis treated with, 1235–1236 Previcox. see Firocoxib dosage of, 90t–91t Protozoal myocarditis, 153–154
immune-mediated diseases treated Priapism, 993–996, 994f–996f, 1034t–1036t Propecia. see Finasteride Protozoal myositis, 1177–1178
with, 1255t–1256t Prilosec. see Omeprazole Propentofylline, 1491 Pseudocyesis, exaggerated, 957
immune-mediated hemolytic anemia Primary adrenal insufficiency, 888–889 Propionibacterium acnes, 1497 Pseudocysts, perinephric, 656–657, 657f
treated with, 1236 Primary autoimmune disease, 1211 Propofol Pseudohyperreflexia, 1047
immune-mediated thrombocytopenia Primary ciliary dyskinesia, 1023 neurologic disorders treated with, Pseudohyponatremia, 918
treated with, 1243 Primary erythrocytosis, 1368, 1369b 1185t–1186t Pseudopregnancy, 949, 957
masticatory muscle myositis treated Primary hepatic lipidosis, 561 status epilepticus treated with, 1105b Pseudorabies, 1541–1542
with, 451 Primary hyperparathyroidism, 758–763 Propranolol, 94 Pseudothrombocytopenia, 1389–1390
pure red cell aplasia treated with, clinical signs of, 759, 760b in cats, 90t–91t Psychogenic polydipsia, 655–656, 741t,
1238–1240 definition of, 758–759 characteristics of, 94t 746–747
Prednisone, 386t–388t, 934t diagnosis of, 760–761, 762f in dogs, 90t–91t Psychomotor seizures, 1094
adverse effects of, 1225t differential diagnosis of, 924, 925f dosage of, 90t–91t Psyllium, 445t
allergic rhinitis treated with, 266 etiology of, 758–760 hypertension treated with, 217t Psyllium hydrocolloid, 515t–517t
azathioprine and, 1224 hypercalcemia caused by, 761t indications for, 94 Puerperal hypocalcemia, 1034t–1036t
canine idiopathic polymyositis treated physical examination of, 760 pharmacokinetics of, 94 Puerperal tetany, 975
with, 1176 prognosis for, 763 toxic effects of, 94 Pulmonary abscess, 343
dosage of, 1222–1223, 1225t signalment, 759 Proprioception, 1136 Pulmonary arterial disease, 201–202
endocrine disorders treated with, treatment of, 761–763 Propulsid. see Cisapride Pulmonary arterial hypertension, 18, 113
896t–897t Primary hypoparathyroidism, 654t–655t, Proscar. see Finasteride Pulmonary artery pressure, 102–103
granulomatous meningoencephalitis 763–766 Prostacyclin, 221 Pulmonary artery systolic pressure,
treated with, 1121b clinical signs of, 764, 764b Prostaglandins, pregnancy termination 30–31
hemolysis treated with, 1235–1236 diagnosis of, 764–765 using, 960 Pulmonary capillary wedge pressure
immune-mediated diseases treated etiology of, 763–764 Prostate gland (PCWP), 52
with, 1255t–1256t hypocalcemia caused by, 765t bacterial prostatitis, 710–711, 710f Pulmonary carcinoma, 293f
description of, 1222–1223, 1222t physical examination of, 764 benign prostatic hyperplasia, Pulmonary edema, 356–358
hemolytic anemia, 1236, 1350 prognosis for, 766 1001–1003, 1002f, 1034t–1036t cardiogenic
polyarthritis, 1203–1204, 1204t, signalment, 764 cystic benign prostatic hyperplasia, cough caused by, 3
1204b treatment of, 765–766 1001–1003, 1002f in dogs, 18
thrombocytopenia, 1243 Primary immune-mediated disorders, infections of, 1002–1003, 1002f, 1446 in cats, 165
joint disease treated with, 1209t–1210t 1211 neoplasia of, 1003, 1003f clinical features of, 356
lymphoplasmacytic rhinitis treated Primary splenic hemangiosarcoma, 1325f Prostatitis, 1441t degenerative atrioventricular valve
with, 269 Probiotics, 443 antibiotics for, 1441t disease as cause of, 121–122,
mast cell tumors treated with, 1333 Procainamide bacterial, 710–711, 710f 121b
masticatory myositis treated with, AV reciprocating tachycardia infectious, 1002–1003, 1002f diagnosis of, 357
1252 prevention using, 80–82 septic, 1003 etiology of, 356, 357b
myasthenia gravis treated with, in cats, 90t–91t Prostigmin. see Neostigmine furosemide for, 358
1251t in dogs, 90t–91t methylsulfate hypoalbuminemia as cause of, 358
neurologic disorders treated with, dosage of, 90t–91t α 1 -Protease inhibitor, 424 lung stiffness caused by, 4
1185t–1186t electrocardiographic changes Protein patterns of, 18
properties of, 1222, 1222t associated with, 49b feline requirements for, 834–835 prognosis for, 358
steroid-responsive tremor syndrome indications for, 91–92 Greyhound levels of, 1362–1363 treatment of, 357–358
treated with, 1122 neurologic disorders treated with, in urine, 665 vascular permeability as cause of, 357
systemic lupus erythematosus treated 1185t–1186t in veterinary therapeutic diets, Pulmonary eosinophilic granulomatosis,
with, 1248–1249 pharmacokinetics of, 92 904t–906t 201
Pregabalin, 1104 toxic effects of, 92 Protein C, 222 Pulmonary fibrosis, idiopathic, 349–352
Pregnancy Procarbazine, 1121b, 1185t–1186t Protein tyrosine phosphatase-like genetic Pulmonary hypertension, 190–210
cesarean section, 972–974, 974f Prochlorperazine, 438, 438t, 515t–517t mutation, 1179–1180 advanced imaging, 192
diagnosis of, 949–950, 949t, 950f Proctoscopy, 427 Protein-calorie malnutrition, 529–530, clinical features of, 354
edema in, 967, 968f Prodrome, 1093 529f clinical findings of, 191
fetal age determination, 950–951, 951f, Productive cough, 282, 283b Protein-losing enteropathy, 495 clinicopathologic findings, 192
951b Proestrus causes of, 401b diagnosis of, 191, 354
fetal heart rate monitoring, 973f canine diarrhea caused by, 399 diseases associated with, 193
gestational age, 950–951, 951f, 951b description of, 937, 938t, 939f fluid therapy in, 434 in dogs, 193
loss of, 962 prolonged, 954–955 in soft-coated wheaten terriers, echocardiographic findings, 192, 192f
palpation detection of, 949–950 feline, 948 497 electrocardiographic findings, 192